Skip to content

C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517988-23-00
Acronym
C6081001
Enrollment
61
Registered
2025-06-19
Start date
Unknown
Completion date
2026-01-07
Last updated
2025-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

KRAS mutated advanced solid tumors

Interventions

None listed

Sponsors

Pfizer Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026